Abiopharma

Bitdeer Announces March 2026 Production and Operations Update

Medicus Pharma to Present New Teverelix Data at AACE 2026 Demonstrating Long-Acting Hormone Suppression

Plus Therapeutics Appoints Randy H. Goodman, PhD, MHA, as Vice President of Value Strategy & HEOR to Advance Market Access and Commercial Execution

World Kinect Corporation to Host First Quarter 2026 Earnings Conference Call on April 23, 2026

Graham Corporation Announces $50 Million Investment from Accounts Advised by T. Rowe Price

Ridgepost Capital Schedules First Quarter 2026 Earnings Release for Thursday, May 7, 2026

Clearmind Medicine Announces Positive Data Safety Monitoring Board Recommendation in ongoing CMND-100 clinical trial

Morgan Stanley Reports First Quarter 2026 Earnings Results

Holdings of interested parties/officers as of 31.3.26

Changes in the companys name and securitys name, effective as of April 17, 2026